trending Market Intelligence /marketintelligence/en/news-insights/trending/GnPFiPierg67G_5I0WT90g2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

Makena Resources, BioCan, Epimeron sign definitive agreement to merge

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Makena Resources, BioCan, Epimeron sign definitive agreement to merge

Makena Resources Inc. said it entered a definitive agreement with BioCan Technologies Inc. and Epimeron Inc. to create a cannabis company through an all-stock merger.

The merged entity will be called Willow Biosciences Inc. and will focus on cannabinoid biosynthetic production.

Calgary, Alberta-based BioCan develops technologies for improved cannabis cultivation, while Epimeron is focused on genetic research to develop new bioproducts from plants.

Under the deal, mining company Makena Resources will issue 857,142,858 shares on the basis of a deemed value of 3.5 Canadian cents per share for a total transaction value of C$30 million.

As part of the transaction, Vancouver, British Columbia-based Makena will issue 7.301 Makena common shares for each BioCan share and 577.153 Makena shares for each Epimeron share.

Completion of the deal is subject to certain conditions, including approval from the shareholders of Makena, BioCan and Epimeron as well as the Court of Queen's Bench of Alberta.

Closing also requires completion of a previously announced C$28.5 million private placement as well as disposal of all of Makena's mining assets.